Current heart attack risk assessment tools like ASCVD and PREVENT may fail to identify many at-risk individuals, highlighting the need for improved early detection and prevention strategies, possibly with cardio imaging.
Colchicine, a gout drug, may prevent heart attacks and strokes. Trials show risk reduction with low doses. More research is needed to confirm benefits and address remaining questions.
REBOOT trial reveals beta-blockers offer no benefit post-heart attack for those with preserved heart function, possibly increasing risks for women. Polypill reduces cardiovascular events.
Research shows sleep deprivation increases heart disease risk by affecting biomarkers & inflammation, even in young, healthy individuals. Exercise helps, but can't replace sleep.
Now a new study shows how low levels of antibodies to the fatty substance phosphorylcholine, called anti-PC, may be a new independent risk marker for cardiovascular disease in older women.
